[ORGANIZATION]
Sunnybrook Health Sciences
Featured in 2 tracked stories · first seen
Situations
Impact of U.S. drug pricing on international medicine access
2 clusters · 7 sources · last updated
Latest: U.S. drug pricing policy delays medicine rollouts in Canada
Pharmaceutical companies are delaying or cancelling the launch of new medications in international markets, specifically Switzerland and Canada, citing concerns over United States drug-pricing policies. In Switzerland,
Also covered in
-
Novartis declines to seek reimbursement for IgAN drug in Canada
[HEALTH] · 6 sources ·